kallyope glp-1 program Addressing the Obesity Epidemic: The Need for New Oral Agents Kallyope's focus on the gut-brain

Patients can expect to lose a significant percentage of their body weight when combined with lifestyle changes

Capitalizing on the evolving obesity market can fail without building innovative sales teams

Provides 500 mg of elemental L-carnitine per capsule A stable form of L-carnitine that is less susceptible to moisture Plays an essential role in energy production from fatty acids Free of synthetic D-carnitine for purity A clean, hypoallergenic formula free of common allergens

How semaglutide and tirzepatide work differently Understanding why these two medications cause different side effects starts with understanding how they work

These should be the main considerations for food and drinks manufacturers when it comes to developing NPD and R&D strategies in a GLP-1 age. For more on Kantars Global and US GLP-1 studies, as well as the new Life After GLP-1 study, click here.